Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 25.03% is in line with its 5-year average of 23.30%, near the high end of its 5-year range (15.34%–27.82%).
0.93% below its 12-month average of 25.27%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 27.82%.
NET PROFIT MARGIN
25.03%
NET PROFIT MARGIN AVG TTM
25.27%
NET PROFIT MARGIN AVG 3Y
23.55%
NET PROFIT MARGIN AVG 5Y
23.30%
NET PROFIT MARGIN AVG 10Y
20.12%
NET PROFIT MARGIN AVG 15Y
17.75%
NET PROFIT MARGIN AVG 20Y
16.28%
CURRENT VS TTM AVG
-0.93%
CURRENT VS 3Y AVG
+6.30%
CURRENT VS 5Y AVG
+7.41%
CURRENT VS 10Y AVG
+24.41%
CURRENT VS 15Y AVG
+41.05%
CURRENT VS 20Y AVG
+53.72%
SECTOR MEDIAN · HEALTHCARE
9.21%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+171.92%
vs the sector median at left
IDEXX Laboratories, Inc.
Market Cap
$39.81B
Net Profit Margin
25.03%
TTM Avg
25.27%
3Y Avg
23.55%
5Y Avg
23.30%
Market Cap
$41.50B
Net Profit Margin
19.53%
TTM Avg
19.27%
3Y Avg
18.75%
5Y Avg
17.94%
Market Cap
$43.09B
Net Profit Margin
8.10%
TTM Avg
8.63%
3Y Avg
8.47%
5Y Avg
7.22%
Market Cap
$43.20B
Net Profit Margin
4.08%
TTM Avg
-0.87%
3Y Avg
-5.42%
5Y Avg
-7.16%
Market Cap
$33.28B
Net Profit Margin
16.82%
TTM Avg
-1.96%
3Y Avg
-34.26%
5Y Avg
-68.70%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IDEXX Laboratories, Inc. (IDXX) | $39.81B | 25.03% | 25.27% | 23.55% | 23.30% |
| Agilent Technologies, Inc. (A)vs › | $41.50B | 19.53% | 19.27% | 18.75% | 17.94% |
| IQVIA Holdings Inc. (IQV)vs › | $43.09B | 8.10% | 8.63% | 8.47% | 7.22% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $43.20B | 4.08% | -0.87% | -5.42% | -7.16% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $33.28B | 16.82% | -1.96% | -34.26% | -68.70% |
| Centene Corp. (CNC)vs › | $32.80B | -2.63% | -0.70% | 0.29% | 0.65% |
| Alcon Inc. (ALC)vs › | $32.20B | 5.92% | 9.84% | 8.46% | 5.10% |
| Biogen Inc. (BIIB)vs › | $32.08B | 8.39% | 15.03% | 17.95% | 19.29% |
| ResMed Inc. (RMD)vs › | $31.66B | 26.94% | 27.08% | 24.30% | 22.30% |
| DexCom, Inc. (DXCM)vs › | $31.33B | 20.12% | 16.12% | 14.73% | 15.57% |
Operating Margin
32.0%
Net Profit Margin
25.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 27.82% |
| 2026-03-31 | 24.41% |
| 2025-12-31 | 22.76% |
| 2025-09-30 | 24.85% |
| 2025-06-30 | 26.50% |
| 2025-03-31 | 24.31% |
| 2024-12-31 | 22.65% |
| 2024-09-30 | 23.87% |
| 2024-06-30 | 20.26% |
| 2024-03-31 | 24.44% |
| 2023-12-31 | 21.58% |
| 2023-09-30 | 23.18% |
| 2023-06-30 | 23.76% |
| 2023-03-31 | 23.78% |
| 2022-12-31 | 20.78% |
| 2022-09-30 | 21.50% |
| 2022-06-30 | 15.34% |
| 2022-03-31 | 23.19% |
| 2021-12-31 | 20.32% |
| 2021-09-30 | 21.62% |
| 2021-06-30 | 24.52% |
| 2021-03-31 | 26.26% |
| 2020-12-31 | 24.24% |
| 2020-09-30 | 20.26% |
| 2020-06-30 | 23.36% |
| 2020-03-31 | 17.85% |
| 2019-12-31 | 14.95% |
| 2019-09-30 | 17.98% |
| 2019-06-30 | 20.27% |
| 2019-03-31 | 17.82% |
| 2018-12-31 | 15.59% |
| 2018-09-30 | 17.10% |
| 2018-06-30 | 18.72% |
| 2018-03-31 | 16.64% |
| 2017-12-31 | 7.56% |
| 2017-09-30 | 14.33% |
| 2017-06-30 | 16.77% |
| 2017-03-31 | 14.94% |
| 2016-12-31 | 11.82% |
| 2016-09-30 | 12.59% |
| 2016-06-30 | 14.40% |
| 2016-03-31 | 11.02% |
| 2015-12-31 | 11.10% |
| 2015-09-30 | 10.88% |
| 2015-06-30 | 13.77% |
| 2015-03-31 | 12.18% |
| 2014-12-31 | 7.38% |
| 2014-09-30 | 13.60% |
| 2014-06-30 | 14.67% |
| 2014-03-31 | 12.93% |
| 2013-12-31 | 12.22% |
| 2013-09-30 | 13.51% |
| 2013-06-30 | 15.31% |
| 2013-03-31 | 13.51% |
| 2012-12-31 | 13.57% |
| 2012-09-30 | 13.58% |
| 2012-06-30 | 15.29% |
| 2012-03-31 | 12.63% |
| 2011-12-31 | 12.37% |
| 2011-09-30 | 12.79% |
| 2011-06-30 | 15.31% |
| 2011-03-31 | 12.51% |
| 2010-12-31 | 12.82% |
| 2010-09-30 | 12.87% |
| 2010-06-30 | 13.21% |
| 2010-03-31 | 12.30% |
| 2009-12-31 | 11.45% |
| 2009-09-30 | 12.17% |
| 2009-06-30 | 12.67% |
| 2009-03-31 | 11.03% |
| 2008-12-31 | 9.68% |
| 2008-09-30 | 10.23% |
| 2008-06-30 | 14.03% |
| 2008-03-31 | 11.06% |
| 2007-12-31 | 10.42% |
| 2007-09-30 | 11.25% |
| 2007-06-30 | 9.14% |
| 2007-03-31 | 9.96% |
| 2006-12-31 | 12.84% |
| 2006-09-30 | 13.32% |
| 2006-06-30 | 13.47% |
| 2006-03-31 | 10.87% |
| 2005-12-31 | 11.99% |
| 2005-09-30 | 13.03% |
| 2005-06-30 | 12.41% |
| 2005-03-31 | 11.61% |
| 2004-12-31 | 11.74% |
| 2004-09-30 | 14.69% |
| 2004-06-30 | 17.40% |
| 2004-03-31 | 13.33% |
| 2003-12-31 | 9.90% |
| 2003-09-30 | 13.30% |
| 2003-06-30 | 13.70% |
| 2003-03-31 | 11.04% |
| 2002-12-31 | 12.05% |
| 2002-09-30 | 11.94% |
